Pyrimidones and imidazolinones for treatment of shock
US5482944A · kind A · utility
0Cited by
2References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 13, 1993 |
| Grant date | Jan 9, 1996 |
| Priority date | — |
| Expiry date | Jul 13, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein X, m, n, R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as defined herein are useful in the treatment of shock and other TNF.alpha.-related disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.